Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Mereo BioPharma Group plc Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market June 14, 2024 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference May 30, 2024 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update May 15, 2024 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference April 03, 2024 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update March 27, 2024 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference March 05, 2024 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments January 08, 2024 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO RARE Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update October 23, 2023 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference September 21, 2023 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma Reports Interim Financial Results for the Six Months Ended June 30, 2023 and Provides Corporate Update September 07, 2023 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma to Present at the Jefferies Healthcare Conference May 31, 2023 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Phase 2 Data from “ASTRAEUS” Trial of Mereo BioPharma’s Alvelestat in Alpha-1 Antitrypsin Deficiency-associated Lung Disease Presented at the 2023 American Thoracic Society International Conference May 23, 2023 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma Regains Compliance with Nasdaq Minimum Bid Price Requirement May 08, 2023 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma Announces Listing Transfer to Nasdaq Capital Market May 05, 2023 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma to Participate in Fireside Chat at the 22nd Annual Needham Healthcare Conference April 13, 2023 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma Reports Full Year 2022 Financial Results and Recent Highlights March 28, 2023 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma Provides Regulatory Updates on Alvelestat for the Treatment of Alpha-1-Antitrypsin Deficiency-Associated Lung Disease March 21, 2023 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma to Participate in Fireside Chat at the SVB Securities Global Biopharma Conference February 08, 2023 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference November 08, 2022 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma Received Notification of Nasdaq Minimum Bid Price Deficiency November 02, 2022 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management October 28, 2022 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma to Host Alvelestat R&D Update Call on October 31, 2022 October 24, 2022 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting October 21, 2022 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma Announces Updated Operating Plan to Maximize Shareholder Value October 18, 2022 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat for Treatment of Alpha-1 Antitrypsin Deficiency (AATD)-associated Lung Disease October 17, 2022 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Mereo BioPharma Confirms Receipt of a Valid Notice Requiring it to Convene a General Meeting of Shareholders October 03, 2022 From Mereo BioPharma Group plc Via GlobeNewswire Tickers MREO Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.